Beta-haemolytic streptococci and antistreptolysin-O titres in patients with rheumatoid arthritis and a matched control group.
D000328:Adult; D000989:Antistreptolysin; D001172:Arthritis, Rheumatoid / Q000276:immunology*; D002623:Chemistry Techniques, Analytical; D019411:Clinical Laboratory Techniques; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D008875:Middle Aged; D013290:Streptococcal Infections / Q000276:immunology*; D013291:Streptococcus / Q000302:isolation & purification
D006046:Gold; D000989:Antistreptolysin
J Exp Med. 1961 Nov 1;114:791-806
13859099
J Clin Invest. 1962 Mar;41:666-75
14007218
Ann Rheum Dis. 1960 Dec;19:338-50
13682375
Ann Rheum Dis. 1959 Mar;18(1):49-51; French transl 51-2; Spanish transl 52-3
13650459
Ann Inst Pasteur (Paris). 1959 Mar;96(3):295-302
13627598
Ann Med Exp Biol Fenn. 1952;30(2):144-8
13040866
J Clin Invest. 1940 Jan;19(1):75-82
16694738
N Engl J Med. 1960 Apr 7;262:687-94
14406625
J Clin Invest. 1935 Sep;14(5):505-15
16694324
Rev Rhum Mal Osteoartic. 1954 May;21(5):399-410
13186620
Am J Hyg. 1959 May;69(3):265-73
13649678
J Clin Invest. 1936 May;15(3):269-75
16694398